Corrigendum to “Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: A challenge for clinical biomarker testing” [Neoplasia 38 (2023) 100884]

The authors regret not to have added the complete supplementary data.

The authors would like to apologise for any inconvenience caused.

Supplementary Figure 6: Immune Checkpoints show a high diversity in expression in different growth patterns of NSCLC metastasis. Expression of different immune checkpoints in (A) acinar, (B) papillary, and (C) solid growth patterns assessed using H-Score. Data are presented as min–max boxplots; Tukey boxplots are used in Figure 4 of the main manuscript. Statistical significance: *=p≤0.05, **=p≤0.01, ***=p≤0.001, ****=p≤0.0001.

Supplementary Figure 7: Comparison of immune checkpoint expression between primary tumor and corresponding lymph node metastasis. Expression of different immune checkpoints in (A) acinar, (B) papillary, and (C) solid growth patterns assessed using H-Score. Data are presented as min–max boxplots, in contrast to the Tukey boxplots used in Figure 5 of the main manuscript. Mean values and standard deviation are shown. Statistical significance: *=p≤0.05, **=p≤0.01.

Supplementary Figure 8: Comparison of immune checkpoint expression in different growth patterns compared to primary tumor. Comparison of immune checkpoints (A) TIGIT, (B) PVR, and (C) Nectin-2. Data are presented as min–max boxplots, in contrast to the Tukey boxplots used in Figure 6 of the main manuscript. Statistical significance: *=p≤0.05, **=p≤0.01, ****=p≤0.0001.